Global Liquid Biopsy Products Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
159
Industry
Diagnostics
Regions
Global
Updated
February 2026

Report Overview


Report Overview
Liquid biopsy products refer to a category of in vitro diagnostic tools that non-invasively analyze biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes from blood, urine, or other body fluids for cancer screening, diagnosis, treatment monitoring, and recurrence prediction. These products span key steps such as sample collection, preservation, nucleic acid extraction, target detection, and data interpretation. Compared to traditional tissue biopsy, liquid biopsy offers advantages in safety, repeatability, and applicability across various cancer types, making it increasingly adopted in clinical settings and showing great potential in precision and personalized medicine.The rapid global advancement of precision medicine and rising cancer incidence form a strong foundation for liquid biopsy adoption. National healthcare systems are increasingly incorporating liquid biopsy into cancer screening and targeted therapy workflows. The declining cost of next-generation sequencing (NGS) and enhanced interpretation capabilities through AI are accelerating product entry into multi-cancer detection and multicenter clinical validation.Despite increasing technological maturity, liquid biopsy still faces challenges in balancing sensitivity and specificity, especially for early-stage cancer detection. Non-uniform standards in sample processing and reagent quality across upstream and downstream components complicate clinical translation. Regulatory hurdles around privacy and bioethics remain significant barriers for global expansion. Broker analyses highlight that most revenue still stems from research-grade orders, and wider clinical adoption and reimbursement pathways require further development.Demand for liquid biopsy is rapidly shifting from research use to routine clinical applications. Monitoring therapeutic response and early relapse detection in high-incidence cancers?such as lung, breast, and colorectal?are driving hospital procurement. Collaboration between biotech companies and hospitals is deepening, with joint labs and multicenter studies becoming the norm. Annual reports also reflect growing patient awareness and preference for non-invasive testing, spurring product expansion into home-testing and mobile diagnostic scenarios.

The global Liquid Biopsy Products market size was estimated at USD 5142.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.40% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Liquid Biopsy Products market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Liquid Biopsy Products market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Liquid Biopsy Products market.
Global Liquid Biopsy Products Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Illumina
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Novogen
BGI
Myriad Genetics
Adaptive Biotechnologies
Biocept
Angle plc
Exact Sciences
Natera
Freenome
Aide Bio
Thermo Fisher Scientific

Market Segmentation (by Type)
CTCs
ctDNA
Exosomes

Market Segmentation (by Application)
Hospitals and Clinics
Third-party Laboratories
Other

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Liquid Biopsy Products Market
Overview of the regional outlook of the Liquid Biopsy Products Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Liquid Biopsy Products Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Liquid Biopsy Products, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Liquid Biopsy Products
    • 1.2 Key Market Segments
      • 1.2.1 Liquid Biopsy Products Segment by Type
      • 1.2.2 Liquid Biopsy Products Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Liquid Biopsy Products Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Liquid Biopsy Products Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Liquid Biopsy Products Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Liquid Biopsy Products Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Liquid Biopsy Products Product Life Cycle
    • 3.3 Global Liquid Biopsy Products Sales by Manufacturers (2020-2025)
    • 3.4 Global Liquid Biopsy Products Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Liquid Biopsy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Liquid Biopsy Products Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Liquid Biopsy Products Market Competitive Situation and Trends
      • 3.8.1 Liquid Biopsy Products Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Liquid Biopsy Products Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Liquid Biopsy Products Industry Chain Analysis
    • 4.1 Liquid Biopsy Products Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Liquid Biopsy Products Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Liquid Biopsy Products Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy ? April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Liquid Biopsy Products Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Liquid Biopsy Products Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Liquid Biopsy Products Sales Market Share by Type (2020-2025)
    • 6.3 Global Liquid Biopsy Products Market Size by Type (2020-2025)
    • 6.4 Global Liquid Biopsy Products Price by Type (2020-2025)
  • 7 Liquid Biopsy Products Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Liquid Biopsy Products Market Sales by Application (2020-2025)
    • 7.3 Global Liquid Biopsy Products Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Liquid Biopsy Products Sales Growth Rate by Application (2020-2025)
  • 8 Liquid Biopsy Products Market Sales by Region
    • 8.1 Global Liquid Biopsy Products Sales by Region
      • 8.1.1 Global Liquid Biopsy Products Sales by Region
      • 8.1.2 Global Liquid Biopsy Products Sales Market Share by Region
    • 8.2 Global Liquid Biopsy Products Market Size by Region
      • 8.2.1 Global Liquid Biopsy Products Market Size by Region
      • 8.2.2 Global Liquid Biopsy Products Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Liquid Biopsy Products Sales by Country
      • 8.3.2 North America Liquid Biopsy Products Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Liquid Biopsy Products Sales by Country
      • 8.4.2 Europe Liquid Biopsy Products Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Liquid Biopsy Products Sales by Region
      • 8.5.2 Asia Pacific Liquid Biopsy Products Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Liquid Biopsy Products Sales by Country
      • 8.6.2 South America Liquid Biopsy Products Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Liquid Biopsy Products Sales by Region
      • 8.7.2 Middle East and Africa Liquid Biopsy Products Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Liquid Biopsy Products Market Production by Region
    • 9.1 Global Production of Liquid Biopsy Products by Region(2020-2025)
    • 9.2 Global Liquid Biopsy Products Revenue Market Share by Region (2020-2025)
    • 9.3 Global Liquid Biopsy Products Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Liquid Biopsy Products Production
      • 9.4.1 North America Liquid Biopsy Products Production Growth Rate (2020-2025)
      • 9.4.2 North America Liquid Biopsy Products Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Liquid Biopsy Products Production
      • 9.5.1 Europe Liquid Biopsy Products Production Growth Rate (2020-2025)
      • 9.5.2 Europe Liquid Biopsy Products Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Liquid Biopsy Products Production (2020-2025)
      • 9.6.1 Japan Liquid Biopsy Products Production Growth Rate (2020-2025)
      • 9.6.2 Japan Liquid Biopsy Products Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Liquid Biopsy Products Production (2020-2025)
      • 9.7.1 China Liquid Biopsy Products Production Growth Rate (2020-2025)
      • 9.7.2 China Liquid Biopsy Products Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Roche
      • 10.1.1 Roche Basic Information
      • 10.1.2 Roche Liquid Biopsy Products Product Overview
      • 10.1.3 Roche Liquid Biopsy Products Product Market Performance
      • 10.1.4 Roche Business Overview
      • 10.1.5 Roche SWOT Analysis
      • 10.1.6 Roche Recent Developments
    • 10.2 Illumina
      • 10.2.1 Illumina Basic Information
      • 10.2.2 Illumina Liquid Biopsy Products Product Overview
      • 10.2.3 Illumina Liquid Biopsy Products Product Market Performance
      • 10.2.4 Illumina Business Overview
      • 10.2.5 Illumina SWOT Analysis
      • 10.2.6 Illumina Recent Developments
    • 10.3 Qiagen
      • 10.3.1 Qiagen Basic Information
      • 10.3.2 Qiagen Liquid Biopsy Products Product Overview
      • 10.3.3 Qiagen Liquid Biopsy Products Product Market Performance
      • 10.3.4 Qiagen Business Overview
      • 10.3.5 Qiagen SWOT Analysis
      • 10.3.6 Qiagen Recent Developments
    • 10.4 Guardant Health
      • 10.4.1 Guardant Health Basic Information
      • 10.4.2 Guardant Health Liquid Biopsy Products Product Overview
      • 10.4.3 Guardant Health Liquid Biopsy Products Product Market Performance
      • 10.4.4 Guardant Health Business Overview
      • 10.4.5 Guardant Health Recent Developments
    • 10.5 MDxHealth
      • 10.5.1 MDxHealth Basic Information
      • 10.5.2 MDxHealth Liquid Biopsy Products Product Overview
      • 10.5.3 MDxHealth Liquid Biopsy Products Product Market Performance
      • 10.5.4 MDxHealth Business Overview
      • 10.5.5 MDxHealth Recent Developments
    • 10.6 Pathway Genomics
      • 10.6.1 Pathway Genomics Basic Information
      • 10.6.2 Pathway Genomics Liquid Biopsy Products Product Overview
      • 10.6.3 Pathway Genomics Liquid Biopsy Products Product Market Performance
      • 10.6.4 Pathway Genomics Business Overview
      • 10.6.5 Pathway Genomics Recent Developments
    • 10.7 NeoGenomics Laboraories
      • 10.7.1 NeoGenomics Laboraories Basic Information
      • 10.7.2 NeoGenomics Laboraories Liquid Biopsy Products Product Overview
      • 10.7.3 NeoGenomics Laboraories Liquid Biopsy Products Product Market Performance
      • 10.7.4 NeoGenomics Laboraories Business Overview
      • 10.7.5 NeoGenomics Laboraories Recent Developments
    • 10.8 Novogen
      • 10.8.1 Novogen Basic Information
      • 10.8.2 Novogen Liquid Biopsy Products Product Overview
      • 10.8.3 Novogen Liquid Biopsy Products Product Market Performance
      • 10.8.4 Novogen Business Overview
      • 10.8.5 Novogen Recent Developments
    • 10.9 BGI
      • 10.9.1 BGI Basic Information
      • 10.9.2 BGI Liquid Biopsy Products Product Overview
      • 10.9.3 BGI Liquid Biopsy Products Product Market Performance
      • 10.9.4 BGI Business Overview
      • 10.9.5 BGI Recent Developments
    • 10.10 Myriad Genetics
      • 10.10.1 Myriad Genetics Basic Information
      • 10.10.2 Myriad Genetics Liquid Biopsy Products Product Overview
      • 10.10.3 Myriad Genetics Liquid Biopsy Products Product Market Performance
      • 10.10.4 Myriad Genetics Business Overview
      • 10.10.5 Myriad Genetics Recent Developments
    • 10.11 Adaptive Biotechnologies
      • 10.11.1 Adaptive Biotechnologies Basic Information
      • 10.11.2 Adaptive Biotechnologies Liquid Biopsy Products Product Overview
      • 10.11.3 Adaptive Biotechnologies Liquid Biopsy Products Product Market Performance
      • 10.11.4 Adaptive Biotechnologies Business Overview
      • 10.11.5 Adaptive Biotechnologies Recent Developments
    • 10.12 Biocept
      • 10.12.1 Biocept Basic Information
      • 10.12.2 Biocept Liquid Biopsy Products Product Overview
      • 10.12.3 Biocept Liquid Biopsy Products Product Market Performance
      • 10.12.4 Biocept Business Overview
      • 10.12.5 Biocept Recent Developments
    • 10.13 Angle plc
      • 10.13.1 Angle plc Basic Information
      • 10.13.2 Angle plc Liquid Biopsy Products Product Overview
      • 10.13.3 Angle plc Liquid Biopsy Products Product Market Performance
      • 10.13.4 Angle plc Business Overview
      • 10.13.5 Angle plc Recent Developments
    • 10.14 Exact Sciences
      • 10.14.1 Exact Sciences Basic Information
      • 10.14.2 Exact Sciences Liquid Biopsy Products Product Overview
      • 10.14.3 Exact Sciences Liquid Biopsy Products Product Market Performance
      • 10.14.4 Exact Sciences Business Overview
      • 10.14.5 Exact Sciences Recent Developments
    • 10.15 Natera
      • 10.15.1 Natera Basic Information
      • 10.15.2 Natera Liquid Biopsy Products Product Overview
      • 10.15.3 Natera Liquid Biopsy Products Product Market Performance
      • 10.15.4 Natera Business Overview
      • 10.15.5 Natera Recent Developments
    • 10.16 Freenome
      • 10.16.1 Freenome Basic Information
      • 10.16.2 Freenome Liquid Biopsy Products Product Overview
      • 10.16.3 Freenome Liquid Biopsy Products Product Market Performance
      • 10.16.4 Freenome Business Overview
      • 10.16.5 Freenome Recent Developments
    • 10.17 Aide Bio
      • 10.17.1 Aide Bio Basic Information
      • 10.17.2 Aide Bio Liquid Biopsy Products Product Overview
      • 10.17.3 Aide Bio Liquid Biopsy Products Product Market Performance
      • 10.17.4 Aide Bio Business Overview
      • 10.17.5 Aide Bio Recent Developments
    • 10.18 Thermo Fisher Scientific
      • 10.18.1 Thermo Fisher Scientific Basic Information
      • 10.18.2 Thermo Fisher Scientific Liquid Biopsy Products Product Overview
      • 10.18.3 Thermo Fisher Scientific Liquid Biopsy Products Product Market Performance
      • 10.18.4 Thermo Fisher Scientific Business Overview
      • 10.18.5 Thermo Fisher Scientific Recent Developments
  • 11 Liquid Biopsy Products Market Forecast by Region
    • 11.1 Global Liquid Biopsy Products Market Size Forecast
    • 11.2 Global Liquid Biopsy Products Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Liquid Biopsy Products Market Size Forecast by Country
      • 11.2.3 Asia Pacific Liquid Biopsy Products Market Size Forecast by Region
      • 11.2.4 South America Liquid Biopsy Products Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Liquid Biopsy Products by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Liquid Biopsy Products Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Liquid Biopsy Products by Type (2026-2035)
      • 12.1.2 Global Liquid Biopsy Products Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Liquid Biopsy Products by Type (2026-2035)
    • 12.2 Global Liquid Biopsy Products Market Forecast by Application (2026-2035)
      • 12.2.1 Global Liquid Biopsy Products Sales (K MT) Forecast by Application
      • 12.2.2 Global Liquid Biopsy Products Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.